March 2021 | Oncology Treatment Pathways®

New HER2-Targeting Therapies Jostle for a Place in the Treatment Lineup

March 06, 2021

The introduction of new therapies for patients with recurrent HER2-positive metastatic breast cancer has resulted in a crowded landscape for third-line treatments and beyond, raising questions about how best to sequence a wealth of options.